Although there was no significant association between Nectin-4 expression and clinicopathological data for the whole cohort and for the entities MuEp, and ACC, a higher Nectin-4 expression was associated with a lower T-stage, absence of lymph node metastases, and absence of vascular or perineural invasion in SaDu. Here, NECTIN4 is linked to adrenal cortex carcinoma.